News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
850,291 Results
Type
Article (86669)
Company Profile (703)
Press Release (762917)
Multimedia
Podcasts (137)
Webinars (17)
Section
Business (232748)
Career Advice (4129)
Deals (39738)
Drug Delivery (129)
Drug Development (91044)
Employer Resources (198)
FDA (18145)
Job Trends (17349)
News (396640)
Policy (39782)
Tag
Academia (3002)
Academic (2)
Accelerated approval (7)
Adcomms (32)
Allergies (100)
Alliances (56913)
ALS (112)
Alzheimer's disease (1532)
Antibody-drug conjugate (ADC) (181)
Approvals (18093)
Artificial intelligence (361)
Autoimmune disease (33)
Automation (18)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (124)
Biotechnology (481)
Bladder cancer (92)
Brain cancer (36)
Breast cancer (368)
Cancer (2835)
Cardiovascular disease (229)
Career advice (3536)
Career pathing (34)
CAR-T (196)
Cell therapy (541)
Cervical cancer (22)
Clinical research (73911)
Collaboration (1006)
Company closure (3)
Compensation (636)
Complete response letters (30)
COVID-19 (2892)
CRISPR (60)
C-suite (306)
Cystic fibrosis (116)
Data (2781)
Decentralized trials (2)
Denatured (48)
Depression (64)
Diabetes (322)
Diagnostics (6953)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (162)
Drug pricing (145)
Drug shortages (35)
Duchenne muscular dystrophy (117)
Earnings (97400)
Editorial (48)
Employer branding (25)
Employer resources (168)
Events (131091)
Executive appointments (862)
FDA (19709)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (913)
Gene editing (137)
Generative AI (36)
Gene therapy (406)
GLP-1 (885)
Government (5201)
Grass and pollen (6)
Guidances (179)
Healthcare (20911)
Huntington's disease (29)
IgA nephropathy (39)
Immunology and inflammation (167)
Immuno-oncology (6)
Indications (35)
Infectious disease (3063)
Inflammatory bowel disease (160)
Inflation Reduction Act (12)
Influenza (63)
Intellectual property (112)
Interviews (813)
IPO (17875)
IRA (53)
Job creations (5191)
Job search strategy (2861)
Kidney cancer (15)
Labor market (51)
Layoffs (577)
Leadership (25)
Legal (10125)
Liver cancer (83)
Lung cancer (404)
Lymphoma (190)
Machine learning (9)
Management (65)
Manufacturing (401)
MASH (90)
Medical device (14679)
Medtech (14684)
Mergers & acquisitions (22511)
Metabolic disorders (861)
Multiple sclerosis (99)
NASH (23)
Neurodegenerative disease (130)
Neuropsychiatric disorders (37)
Neuroscience (2221)
NextGen: Class of 2025 (7686)
Non-profit (5087)
Now hiring (44)
Obesity (455)
Opinion (283)
Ovarian cancer (96)
Pain (111)
Pancreatic cancer (106)
Parkinson's disease (183)
Partnered (25)
Patents (283)
Patient recruitment (139)
Peanut (53)
People (65524)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22826)
Phase II (32100)
Phase III (24160)
Pipeline (1581)
Policy (204)
Postmarket research (3552)
Preclinical (10298)
Press Release (72)
Prostate cancer (136)
Psychedelics (39)
Radiopharmaceuticals (276)
Rare diseases (485)
Real estate (7397)
Recruiting (75)
Regulatory (26962)
Reports (61)
Research institute (2663)
Resumes & cover letters (649)
Rett syndrome (9)
RNA editing (9)
RSV (52)
Schizophrenia (90)
Series A (156)
Series B (105)
Service/supplier (30)
Sickle cell disease (62)
Special edition (21)
Spinal muscular atrophy (166)
Sponsored (35)
Startups (4297)
State (2)
Stomach cancer (16)
Supply chain (79)
Tariffs (62)
The Weekly (87)
Vaccines (859)
Venture capitalists (49)
Weight loss (312)
Women's health (45)
Worklife (20)
Date
Today (69)
Last 7 days (620)
Last 30 days (2997)
Last 365 days (34831)
2025 (15830)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (66)
Alaska (7)
Arizona (277)
Arkansas (14)
Asia (50363)
Australia (8854)
California (7340)
Canada (2273)
China (657)
Colorado (313)
Connecticut (327)
Delaware (186)
Europe (115543)
Florida (1078)
Georgia (248)
Hawaii (1)
Idaho (65)
Illinois (703)
India (31)
Indiana (365)
Iowa (16)
Japan (213)
Kansas (115)
Kentucky (30)
Louisiana (17)
Maine (73)
Maryland (1051)
Massachusetts (5610)
Michigan (265)
Minnesota (456)
Mississippi (3)
Missouri (95)
Montana (32)
Nebraska (26)
Nevada (78)
New Hampshire (72)
New Jersey (2040)
New Mexico (31)
New York (2054)
North Carolina (1202)
North Dakota (10)
Northern California (3170)
Ohio (242)
Oklahoma (16)
Oregon (48)
Pennsylvania (1572)
Puerto Rico (17)
Rhode Island (39)
South America (1653)
South Carolina (32)
South Dakota (1)
Southern California (2708)
Tennessee (120)
Texas (1103)
United States (27737)
Utah (216)
Virginia (194)
Washington D.C. (78)
Washington State (655)
West Virginia (4)
Wisconsin (80)
There are 850,291 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals
June 9, 2025
·
8 min read
Press Releases
Merck Announces Positive Topline Results From the First Two Phase 3 CORALreef Trials Evaluating Enlicitide Decanoate for the Treatment of Adults With Hyperlipidemia
June 9, 2025
·
8 min read
Press Releases
Avidity Biosciences Announces the Accelerated Approval Regulatory Pathway in the U.S. is Open for Del-Brax and Initiates the Global, Confirmatory Phase 3 FORWARD™ Study in FSHD
June 9, 2025
·
13 min read
Press Releases
Avidity Biosciences Announces Positive Topline Phase 1/2 FORTITUDE™ Data Demonstrating Consistent Improvement Across Multiple Functional Measures Compared to Placebo in Del-Brax Treated FSHD Participants
June 9, 2025
·
12 min read
Press Releases
George Medicines announces FDA approval of WIDAPLIK™ (telmisartan, amlodipine and indapamide), a new single pill combination treatment for hypertension in adults, including initial treatment
June 9, 2025
·
9 min read
Press Releases
Axsome Therapeutics Provides Update on the New Drug Application (NDA) for AXS-14 for the Management of Fibromyalgia
June 9, 2025
·
7 min read
Press Releases
TransCon® hGH Boosted Treatment Benefits of TransCon® CNP in Children with Achondroplasia at Week 26 Interim Analysis of the Phase 2 COACH Trial
June 9, 2025
·
9 min read
Press Releases
Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy
June 9, 2025
·
10 min read
Press Releases
Metsera Announces Positive Phase 1 Data of First-in-Class Once-Monthly Amylin Candidate MET-233i
June 9, 2025
·
9 min read
Press Releases
SEED Therapeutics Appoints Dr. Bill Desmarais as Chief Financial Officer and Chief Business Officer
June 9, 2025
·
2 min read
1 of 85,030
Next
